首页> 美国卫生研究院文献>Frontiers in Pharmacology >Assessing the Pharmacological and Therapeutic Efficacy of Traditional Chinese Medicine Liangxue Tongyu Prescription for Intracerebral Hemorrhagic Stroke in Neurological Disease Models
【2h】

Assessing the Pharmacological and Therapeutic Efficacy of Traditional Chinese Medicine Liangxue Tongyu Prescription for Intracerebral Hemorrhagic Stroke in Neurological Disease Models

机译:在神经疾病模型中评估中药凉血通瘀方对脑出血性中风的药理和治疗功效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Intracerebral hemorrhage is a fatal subtype of stroke, with crucial impact on public health. Surgical removal of the hematoma as an early-stage treatment for ICH can’t improve long-term prognosis remarkably. Liangxue tongyu prescription (LP), a Traditional Chinese Medicine (TCM) formula, includes eight ingredients and has been used to treat ICH in the clinical. In the study, we elucidated the pharmacological efficacy and therapeutic efficacy of LP to dissect the mechanism of LP against ICH via network analysis and experimental validation. First, we discovered 34 potential compounds and 146 corresponding targets in LP based on network prediction. 24 signal pathway were obtained by the Clue Go assay based on potential compounds in LP against ICH. Second, we found that LP can not only decreased the level of high sensitive C reactive protein (HS-CRP), tumor necrosis factor-α (TNF-α), NF-kβ, D-dimmer (D2D), estradiol (E2), S-100B, neuron specific enolase (NSE), and interleukin 1 (IL-1) in plasma on spontaneously hypertensive rats (SHRs), but also promoted cell proliferation and inhibited cell apoptosis on the glutamate-induced PC12 cell. The compounds including Taurine, Paeonol, and Ginsenoside Rb1 in LP can activate PI3K/AKT pathway. Third, from the three-factor two-level factorial design, compound combinations in LP, such as Taurine and Paeonol, Taurine and Geniposide, Ginsenoside Rg1, and Ginsenoside Rb1, had first-level interactions on cell proliferation. Compound combinations including Taurine and Paeonol, Ginsenoside Rg1 and Ginsenoside Rb1 had as significant increase in efficiency on inhibiting the apoptosis of PC12 cells at the low concentration and up-regulating of PI3K and AKT. Overall, our results suggested that LP had integrated therapeutic effect on ICH due to activities of anti-inflammatory, anti-coagulation, blood vessel protection, and protection neuron from excitotoxicity based on the way of “multi-component, multi-target, multi-pathway,” and compound combination in LP can offer protection neuron from excitotoxicity at the low concentration by activation of the PI3K/Akt signal pathway.
机译:脑出血是中风的致命亚型,对公共卫生具有至关重要的影响。外科手术切除血肿作为ICH的早期治疗不能显着改善长期预后。凉血通榆方剂(LP)是一种中药(TCM)配方,包含八种成分,已在临床上用于治疗ICH。在这项研究中,我们通过网络分析和实验验证阐明了LP的药理功效和治疗功效,以剖析LP抗ICH的机制。首先,基于网络预测,我们在LP中发现了34种潜在化合物和146种相应目标。基于针对ICH的LP中潜在的化合物,通过Clue Go分析获得了24条信号通路。其次,我们发现LP不仅可以降低高敏C反应蛋白(HS-CRP),肿瘤坏死因子-α(TNF-α),NF-kβ,D-二聚体(D2D),雌二醇(E2)的水平,自发性高血压大鼠(SHRs)血浆中的S-100B,神经元特异性烯醇化酶(NSE)和白介素1(IL-1),但在谷氨酸诱导的PC12细胞上也能促进细胞增殖并抑制细胞凋亡。 LP中的牛磺酸,丹皮酚和人参皂苷Rb1等化合物可以激活PI3K / AKT途径。第三,从三因素两级因子设计中,LP中的牛磺酸和丹皮酚,牛磺酸和Gen子苷,人参皂苷Rg1和人参皂苷Rb1的化合物组合在细胞增殖方面具有一级相互作用。牛磺酸和丹皮酚,人参皂苷Rg1和人参皂苷Rb1等化合物组合在低浓度下抑制PC12细胞凋亡以及上调PI3K和AKT的效率显着提高。总体而言,我们的研究结果表明,基于“多组分,多靶点,多靶点,多靶点,多靶点,多靶点,多靶点,多靶点和多靶点LP中的化合物和化合物组合可通过激活PI3K / Akt信号通路,在低浓度下保护神经元免受兴奋性毒性作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号